PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference

Rhea-AI Summary

PROCEPT BioRobotics (Nasdaq: PRCT) said members of management will present at two investor conferences in March 2026: a fireside chat at TD Cowen in Boston on March 2, 2026 at 11:40am ET and a fireside chat at Leerink in Miami on March 10, 2026 at 8:00am ET.

A live webcast and archived recordings will be available on the company Investors website and retained for at least 90 days after each event.

News Market Reaction – PRCT

-0.89%

1 alert

-0.89% News Effect

-$14M Valuation Impact

$1.53B Market Cap

1.4x Rel. Volume

On the day this news was published, PRCT declined 0.89%, reflecting a mild negative market reaction. This price movement removed approximately $14M from the company's valuation, bringing the market cap to $1.53B at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

TD Cowen fireside chat time: 11:40 a.m. ET Leerink fireside chat time: 8:00 a.m. ET Webcast archive period: 90 days

3 metrics

TD Cowen fireside chat time 11:40 a.m. ET TD Cowen 46th Annual Health Care Conference on March 2, 2026

Leerink fireside chat time 8:00 a.m. ET 2026 Leerink Global Health Care Conference on March 10, 2026

Webcast archive period 90 days Replay availability after each conference event

Market Reality Check

Price: $27.27 Vol: Volume 847,157 is below t...

normal vol

$27.27 Last Close

Volume Volume 847,157 is below the 20-day average of 1,086,508 (relative volume 0.78). normal

Technical Shares at $29.19 are trading below the 200-day MA of $42.97 and 61.23% below the 52-week high of $75.29, while sitting about 5% above the 52-week low of $27.80.

Peers on Argus

PRCT is up 0.17% with mixed moves among peers: ATEC and QDEL up 1.45%, while INS...

PRCT is up 0.17% with mixed moves among peers: ATEC and QDEL up 1.45%, while INSP down 1.9%, HAE down 0.49%, and LIVN down 1.23%, indicating stock-specific trading rather than a unified sector move.

Historical Context

5 past events · Latest: Jan 26 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 26	Earnings call & Investor Day	Neutral	+1.6%	Announced 4Q25 earnings call and Investor Day with webcast access.
Nov 20	Investor conference appearance	Neutral	-0.1%	Planned presentation at Piper Sandler healthcare conference with webcast replay.
Nov 04	Earnings and guidance	Positive	+1.5%	Reported Q3 2025 growth, margin expansion, and 2026 revenue guidance.
Oct 15	Earnings date announcement	Neutral	+0.5%	Set date and time for Q3 2025 results call and webcast details.
Oct 07	Peer financing & trial	Positive	-1.8%	Peer Jupiter Endovascular closed oversubscribed Series B and outlined trial plans.

Pattern Detected

Earnings-related updates have generally seen positive price reactions, while peer or neutral conference headlines show mixed responses.

Recent Company History

Recent news for PRCT has focused on earnings progress and investor engagement. An announcement of a 4Q25 earnings call and Investor Day on Feb 24–25, 2026 coincided with a +1.65% move. Prior notices of upcoming earnings calls and conferences around Nov 2025 saw modest positive or slightly negative reactions. The Q3 2025 earnings release with strong revenue growth and guidance produced a +1.48% move. A peer-focused financing headline in Oct 2025 corresponded with a -1.79% reaction, highlighting that external sector news can weigh on shares.

Market Pulse Summary

This announcement highlights PRCT’s participation in two March investor conferences, with fireside c...

Analysis

This announcement highlights PRCT’s participation in two March investor conferences, with fireside chats and webcasts archived for at least 90 days. Recent history shows that formal earnings releases and guidance have been more meaningful catalysts than conference scheduling updates. Shares currently sit below the 200-day MA and well under the 52-week high, so investors may focus more on upcoming earnings events, capital allocation disclosures, and operating trends than on conference appearances themselves.

AI-generated analysis. Not financial advice.

SAN JOSE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of management will present at two upcoming investor conferences in March.

TD Cowen 46^th Annual Health Care Conference

• Location – Boston, MA
• Fireside Chat – Monday, March 2^nd at 11:40am ET

2026 Leerink Global Health Care Conference

• Location – Miami, FL
• Fireside Chat – Tuesday, March 10^th at 8am ET

A live webcast of each event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com. The webcasts will be archived and available for replay for at least 90 days after the event.

About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics’ mission is to revolutionize BPH treatment globally in partnership with urologists by delivering best-in-class robotic solutions that positively impact patients and drive value. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS® Robotic Systems. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States.

Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@procept-biorobotics.com

FAQ

When will PROCEPT BioRobotics (PRCT) present at the TD Cowen 46th Annual Health Care Conference?

The presentation is scheduled for March 2, 2026 at 11:40am ET. According to the company, management will participate in a fireside chat in Boston and a live webcast will be available on the company Investors website for viewing.

What time and date is PROCEPT BioRobotics (PRCT) presenting at the 2026 Leerink Global Health Care Conference?

PROCEPT will present on March 10, 2026 at 8:00am ET. According to the company, the session is a fireside chat in Miami and it will be webcast live with an archived replay accessible afterward.

Where can investors watch the PROCEPT BioRobotics (PRCT) conference webcasts and recordings?

Investors can watch via the company's Investors website at the provided IR URL. According to the company, each event will be webcast live and archived on the Investors site for at least 90 days after the event.

How long will PROCEPT BioRobotics (PRCT) keep archived webcasts from the March 2026 conferences available?

Archived webcasts will be retained for at least 90 days after each event. According to the company, both the TD Cowen and Leerink session recordings will be accessible on the Investors website for replay during that period.

Will PROCEPT BioRobotics (PRCT) management presentations at the March 2026 conferences be live or pre-recorded?

The company indicated the sessions will be presented live as fireside chats and webcast in real time. According to the company, live webcasts and archived recordings will both be provided on the Investors website for later viewing.